substances (NPS) and labelled with drug associated nomenclature (Van Hout 2012) . Use of NPS was not confined to problematic drug users, and included social recreational users (McElrath and Van Hout 2011; Van Hout and Brennan 2011a; Van Hout and Bingham 2012) . Decisions to try NPS were reportedly influenced by 24 h availability and pricing, home delivery, advertising, perceived level of protection and distance from the illegal drug trade, and lack of confirmed urine analysis for those in the treatment system (Van Hout and Brennan 2011a, b, c; Ryall and Butler 2011; McElrath and Van Hout 2011; Van Hout and Bingham 2012) . Users appeared to perceive products as safe, with little awareness around lack of regulation and risk relating to toxicity (Van Hout 2012) . Clinical concerns at the time centred on the rise in presentation of users with psychosis and suicidal ideation (Tully et al. 2011; O'Domhnail and Ni Chleirigh 2011; El-Higaya et al. 2011; Uhoegbu et al. 2011) .
Political and social concern contributed to a series of national legislative controls in 2010 and more recently in 2015 (Ryall and Butler 2011; Health Research Board 2016) . Prelegislative studies indicated that Irish NPS users were not deterred by impending legislative controls, and reported stockpiling of products (particularly the synthetic cathinone, Mephedrone) and accessing of online retailers (McElrath and Van Hout 2011; Van Hout and Brennan 2011a, 2011b) . Small-scale post legislative studies reported on a 'temporary displacement' with users either ceasing use or switching back to the conventional street sourcing (Van Hout and Brennan 2011a, b; McElrath and Van Hout 2011) . In later years, legislative controls were speculated to have incurred some positive results, with small scale studies reporting on reduction of cathinone derivatives in post-mortem blood samples and urine samples of methadone programme patients (Kavanagh and Power 2014) ; and reduced prevalence of NPS use in high risk youth (Smyth et al. 2015) ; and treated heroin dependent adults (O'Byrne et al. 2013 ). The Eurobarometer (2014) has however reported on increases in young persons (15-24 years) use in Ireland. In 2016, studies have reported on problematic use of synthetic cannabinoids (SCBs), 5f-AKB48 and 5F-PB-22 in border counties (Van Hout and Hearne 2016), the rise in HIV incidence among people who inject drugs (PWID) using the synthetic cathinone, a-PVP (Giese et al. 2015) and media reporting on the spate of hospitalisations and fatalities due to consumption of other popular NPS; a-PVP, the stimulant 4-methoxy analog of methamphetamine (PMMA), the synthetic psychedelics 2,5-dimethoxy-4-bromophenethylamine (2C-B), the psychedelic phenethylamines (2-CP, 2-Cl) and the derivative of 2-CI, 25I-NBOMe. This brief report presents descriptive findings from a consultation with national and regional health professional experts on the NPS phenomenon in Ireland in 2016.
Methods
The study aimed to investigate expert perspectives on the NPS situation in Ireland with regard to changing and emergent trends in use, health and social consequences and service implications. A qualitative study using a structured guide was conducted with 13 national and regional health professional experts across Ireland (Republic), and was undertaken as part of a large scale European funded study across five Member States. Participants were selected based on their expert status, (national and if not national, their regional status representing all regions in Ireland), and secondly their expertise in the area of NPS, public health and addiction treatment. Participants represented national child protection and welfare, addiction psychiatry, harm reduction and addiction treatment; and regional drug education, community drug and alcohol services, primary care addiction treatment and rehabilitation, and clinical service management. Ethical approval for the study was granted by Waterford Institute of Technology, Ireland in 2016. All participants were provided with information around the study's aims, advised of confidentiality and anonymity, with participation indicating informed consent.
A structured guide of questions was designed by the NPS Transnational Team (see www. npstransnational.org) based on the literature, and prior experiences in conducting research on NPS. The guide was administered to participants and contained questions relating to the participant profile, their professional role as it related to NPS, their experience of types of NPS users, patterns of use and harms related to NPS use, their views on specific supply, demand and harm reduction approaches. The final data set consisting of 14,450 words was analysed using content analysis. This involved application of a structured, systematic coding scheme, in the form of open, axial and selective coding categories derived directly from the text (Hsieh and Shannon 2005) . Four descriptive themes emerged from the data.
Results
Four females and nine males, with ages ranging from 30 to 59 years partook. Duration of professional experience ranged from 8 to 37 years (average 18 years), with four participants responsible for and operating within national health policy, clinical and addiction service levels, and the remainder responsible for regional remit of education, addiction treatment in primary care and community drug services.
Definitions of NPS Used within Professional Roles
Definitions of NPS varied according to the participant's professional role, and were generally confined within the regulatory domain and Irish legislative context. Many participants labelled NPS within the context of products sold in headshops prior to 2010 and defined them as 'head shop products' and legal highs^. Many referred to NPS by type/brand name, for example 'Mephedrone /Spice' or according to their psychoactive effect.
'I define them as either stimulant or depressant, and identify them by the name that the service user calls them BSpice, Bath Salts, Incense^or if they have fitted a known validated description'.
Participants described at length the dynamic nature of the designer NPS market and how surveillance and detection struggle to tackle continuously adapted products. Challenges in verification of NPS centred on chemical detection in drug seizures and urine analysis. Undetected compounds purchased on the Internet and entering Ireland via the postal system are labelled as 'research chemical'; 'animal or herbal products'.
'NPS are changing faster than the regulatory definitions, and indeed than the scientific community can confidently identify them.'
Professional Experiences of NPS
Contact with NPS users depended on level of case load contact, and ranged from referrals from schools, parents, social workers and Gardai (Irish police) through to daily case load with service users. Difficulties in estimating extent of NPS use in Ireland despite the rise in service concerns and increased referrals within the context of poly substance use, centred on lack of detection in urine screening (in treatment and prison settings), and prevalence surveillance.
'Difficult to quantify but services state that there is increasing use reflected in profile of clients presenting to services, as element of poly-drug use presentations.'
'As the NPS in vogue are being used on the street, we would often find that we are noticing a population effect'.
A lack of user awareness of harm and potential for overdose was described by many participants, particularly in the case of younger, more inexperienced users. Concerns centred on the rise in serious mental health admissions, and difficulties in treatment.
'The user cannot tell when the desired effect will begin, crescendo, or when the hangover will subside. This may be at odds with the seller's description or the users perception, and may result in unintended consequences, such as doubling up the dose, or significant post use depression, similar to BSuicide Tuesday^from cocaine use. There are also significant short and long-term mental health effects from NPS, which have yet to be evaluated to the same degree as say cannabis and psychosis.'
Types of NPS Users, Sourcing and Consequences of Use
Participants recognised the wide range of NPS use across the Irish population. Specific groups of NPS users were identified, with some not engaging with health services, 1) College students or young people at parties; 2) 'Chemsex' men who have sex with men (MSM); 3) Entrenched PWID seeking a cheap high not undetectable by routine screening; 4) Co-morbid individuals with (often) primary mental illness and self-medicating.
'There is a novice user who perceives less risk associated with NPS under the guise of disarming names, and street culture. These include party & festival goers and students. There is a regular pill user, who sees themselves as Bstreet wise^and likes to think they know a lot about the different types of tablets and NPS being traded, and perceives they are in control of the NPS effects by balancing their use between Buppers and downers^. Then there is the chaotic drug user, who is taking NPS as part of polydrug use, in an attempt to maintain a habit, or keep withdrawal symptoms at bay'.
Poly substance use including a repertoire of NPS and conventional drugs was described as common, with popular NPS including SCBs, psychedelics, gamma-Hydroxybutyric acid (GHB) alternatives, psychedelic phenethylamines containing the 2-C substances, and cathinone stimulants such as a-PVP and Mephedrone. More recent trends included the opioid fentanyl analogue, flurofentanyl. Route of administration varied, with PWID and 'Chemsex' users often injecting, and recreational users in social night life ingesting, insufflating or smoking. General reasons for use of NPS centred on user curiosity, social influences, availability in the form of a 'cheap high', potency in comparison to conventional drugs, and for pleasure.
'For a 'high', curiosity, enhance sexual experience, inexpensive or in some cases free, 'everyone else at the party was using'
Participants distinguished between types of user in relation to sourcing methods, with PWID sourcing via existing street and peer networks, and social and 'Chemsex' users purchasing online and from friends. The internet was used by less chaotic users to source information on the Surface and Dark Net, with availability supported via mobile phone technology and social media.
'Students tend to get substances off friends. PWID tend to get from dealers. Chemsex may access drugs via websites and online shops with delivery to door'.
Consequences of NPS use centred on short term impacts such paranoia, heightened aggression and sexual risk taking, insomnia and increased injecting risk behaviours in PWID. The stimulant nature of the NPS injected was observed to contribute to worsening outcomes relating to reduced harm reduction and compulsive re-dosing. Those engaging in injecting of NPS were reported to experience bacterial infections, cellulitis, phlebitis, deep vein thrombosis (DVT), and weight loss, and more significantly than opiate injectors. Longer term impacts centred on unpleasant withdrawals, virus transmission (HIV and HCV), and deterioration of mental state.
'Short term agitation, anxiety, aggression. Some reports of increased sexual activity. Serious sleep deprivation for stimulant based substances. Serious impact on mental health. Reports of drug induced psychosis and long term mental health problems such as depression.'
An increase in severity and progression of dependence symptomatologies were described, and particularly negative in terms of mental health impact.
'More highly addictive and quicker to form habits. Cessation has a higher negative effect on the mental health'.
Particular concerns were voiced with regard to deterioration of mental health in the form of emotional instability, suicidal ideation and prevalence of inappropriate, violent and unpredictable behaviours, and the risks of acute psychosis and the onset of enduring mental health issues for those that are already vulnerable. Psychotic episodes were described as difficult to treat and usually requiring long periods of hospitalisation.
Service Response
Participants underscored the need for national evidence based approach to clearly address emerging issues in NPS. Harm reduction efforts were recommended to include information on adverse acute and long term consequences of use, and supported by universal face to face, peer dissemination and internet campaigns targeting the different types of NPS users and those affected in their social network.
'The primary target audience for the current National Drug Strategy is aimed at opiate users which doesn't meet the needs of the NPS population The development of a new strategy needs to reflect information in regards to prevention, early identification, early intervention and putting more resources into supporting protective factors.'
The need for enhanced targeted treatment and rehabilitation, and dual diagnosis service responses to address the poly substance using trends and particular consequences of NPS use appeared warranted.
'NPS are not recognised within treatment and rehabilitation pillars of National Drug Strategy, or prevention in relation to being able to deal with people who present with these issues. It has no clear dual diagnosis strategic objectives or actions. Mental health and psychosis are extreme in cases of NPS use and there are very limited dual diagnosis services.'
Clinical services were deemed ill-equipped to deal with the repercussions of NPS use and dependence, with participants highlighting the need for clinical guidance, enhanced collaboration between addiction and mental health services, and additional staff training and resources.
'Currently there is a scarcity of inpatient treatment facilities trained effectively to cope with NPS. Staff within services do not understand a lot of these drugs and their implications so adequate training is required.'
Discussion
Increasing trends in the diversification, trafficking and use of NPS continue to present a global public health challenge (European Monitoring Centre for Drugs and Drug Addiction 2015). Surveillance struggles to keep up with the ever increasing range of NPS with undocumented toxicological and psycho-activity risks (EMCDDA 2015; Caudevilla et al. 2013 : Caudevilla 2016 . The Internet is also driving change in contemporary global drug markets, and particularly that of NPS (EMCDDA 2015; Lavorgna 2014 Lavorgna , 2016 van Amsterdam et al. 2015) . The study illustrated a descriptive 'snapshot' of expert perspectives on the current situation around NPS trends, sourcing routes, health and social consequences and service responses in Ireland. Limitations centre on its small scale nature, despite key national and regional expert representation.
Legislative challenges were viewed to centre on the detection in chemical analysis of NPS entering Ireland via the postal system, and also in the urine screening of users in prison and treatment settings. Irish academics have highlighted the need for legislation to support collaborative intelligence gathering activities (Kavanagh and Power 2014) . For the most part legal status, legislative controls and regulation according to these experts had succeeded in closing headshop routes to supply, but with street and online availability contributing to continued and undeterred use of NPS among diverse populations of NPS users. The Global Drugs Survey (2016) has reported that almost 10 % of Irish users buy drugs on the internet, of which a third are NPS. Social media is also playing a major role in the marketing and sale of NPS (Orsolini et al. 2015) , and in the supporting of BChemsex^participation (Lewnard and Berrang-Ford 2014; Gilbart et al. 2014) .
Trends in poly substance use of popular NPS included synthetic cannabinoids, stimulant and psychedelic drugs. Motives for use are similiar to that reported elsewhere (Van Hout 2014; Van Hout and Hearne 2015; Soussan and Kjellgren 2016; GDS 2016) . Despite legislation viewed as cross cutting between law enforcement and health (Ryall and Butler 2011) ; service responses and preventative measures have not kept up with the increase in poly drug referrals which involve NPS, and the diverse range of NPS used in Ireland. Experts underscored concerns around service provision and clinical responses to the serious mental and physical health consequences of NPS, most often within poly drug repertoires, and compounded when injected. For those engaged in high risk behaviour such as 'Chemsex' and/or injecting drug use, risks of blood borne virus transmission are a significant concern (Giese et al. 2015; European Chemsex Forum 2016 ). An investment in staff training and resources, within an evidence based approach is required in order to address the challenges relating to NPS use, and particularly now in the formulation of the next National Drug Strategy to support multidisciplinary efforts in prevention and treatment cognisant of the dual diagnosis complications.
Conclusion
The study whilst small scale is unique in terms of providing the national and regional snapshot of expert perspectives around NPS use in Ireland. Whilst legislation has reduced shop sales of NPS, online retail and influx of psychoactive substances into Ireland via the postal system remains an issue. Best practices from elsewhere are warranted to inform the new National Drug Strategy from 2017 onwards, and support prevention, harm reduction and clinical responses.
